SIGNIFICANT ACCOUNTING POLICIES (Details 8) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Patents and other intangibles
Additions	$ 3,128,000	$ 50,415,000
Accumulated Amortization
Balance at the beginning of the period	10,400,000
Amortization expenses	4,761,000	1,552,000	1,300,000
Balance at the end of the period	15,160,000	10,400,000
Net
Balance at the beginning of the period	56,379,000	7,516,000
Additions	3,128,000	50,415,000
Write-offs and other adjustments, net	148,000
Amortization expense	(4,761,000)	(1,552,000)	(1,300,000)
Balance at the end of the period	54,894,000	56,379,000	7,516,000
Estimated aggregate amortization expense for definite lived intangible assets for each of the five years ending December 31 and thereafter:
2012	4,830,000
2013	4,821,000
2014	4,804,000
2015	4,748,000
2016	4,107,000
Thereafter	31,584,000
Total	54,894,000
Marketing
Marketing costs, including advertising	3,900,000	4,300,000	3,500,000
Patient-Care Centers
Patents and other intangibles
Balance at the beginning of the period	15,873,000	14,025,000
Additions	3,128,000	2,315,000
Write-offs and other adjustments	(1,000)	(467,000)
Balance at the end of the period	19,000,000	15,873,000
Accumulated Amortization
Balance at the beginning of the period	9,073,000	8,554,000
Write-offs and other adjustments, amortization		(467,000)
Amortization expenses	995,000	986,000
Balance at the end of the period	10,068,000	9,073,000
Net
Balance at the beginning of the period	6,800,000	5,471,000
Additions	3,128,000	2,315,000
Write-offs and other adjustments, net	(1,000)
Amortization expense	(995,000)	(986,000)
Balance at the end of the period	8,932,000	6,800,000
Distribution
Patents and other intangibles
Balance at the beginning of the period	2,604,000	2,604,000
Balance at the end of the period	2,604,000	2,604,000
Accumulated Amortization
Balance at the beginning of the period	896,000	640,000
Amortization expenses	257,000	256,000
Balance at the end of the period	1,153,000	896,000
Net
Balance at the beginning of the period	1,708,000	1,964,000
Amortization expense	(257,000)	(256,000)
Balance at the end of the period	1,451,000	1,708,000
Therapeutic Solutions
Patents and other intangibles
Balance at the beginning of the period	48,300,000	200,000
Additions		48,100,000
Write-offs and other adjustments	(149,000)
Balance at the end of the period	48,449,000	48,300,000
Accumulated Amortization
Balance at the beginning of the period	429,000	119,000
Amortization expenses	3,509,000	310,000
Balance at the end of the period	3,938,000	429,000
Net
Balance at the beginning of the period	47,871,000	81,000
Additions		48,100,000
Write-offs and other adjustments, net	149,000
Amortization expense	(3,509,000)	(310,000)
Balance at the end of the period	$ 44,511,000	$ 47,871,000
Non-compete agreements
Goodwill and Other Intangible Assets
Minimum useful life of identified intangible asset (in years)	5
Maximum useful life of identified intangible asset (in years)	7
Other definite-lived intangible assets
Goodwill and Other Intangible Assets
Maximum useful life of identified intangible asset (in years)	20